SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board
Sinovac Biotech Retains Support from Proxy Advisors Ahead of Crucial Vote
Sinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special Meeting
SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE Shares
Glass Lewis & Co. Recommends Stockholders Support AJP/Orbic's Campaign for Real and Immediate Board Change at Sonim Technologies
Advisory firm Glass Lewis backs Toyota chairman re-election
By Sandra Maler, Leslie Adler & Daniel Leussink
Shareholder adviser Glass Lewis joins political retreat
By Liz Hoffman & Rohan Goswami
Glass Lewis backs Generali CEO Donnet for another term
By Gianluca Semeraro & barbara lewis
Heritage Playbook Sets Up Antitrust Pressure on Proxy Advisers
By Justin Wise & Andrew Ramonas
Shareholder Adviser ISS Kills Diversity Criteria for Boards
By Jeff Green & Saijel Kishan
Monte dei Paschi investors should back bid for Mediobanca, Glass Lewis says
By Valentina Za, Alvise Armellini & Raju Gopalakrishnan
Latest Changes to ISS and Glass Lewis Proxy Voting Guidelines
By Stephen Calvin Hinton
Glass Lewis recommends voting against CEO pay at Goldman Sachs
By Ross Kerber & Rod Nickel
ISS and Glass Lewis 2025 proxy season updates
By Katherine Prusinkiewicz
James Uthmeier launches probe of two proxy advisers, alleging illegal ESG policies, collusion
By Jesse Scheckner
Two Firms Hazardous To Shareholder Health
By Steve Forbes
Proxy adviser takes aim at Woodside
By Brad Thompson